| Title | Date |
|---|
| MS Trial Alert: Investigators Nationwide Recruiting People with All Types of MS for Early, Phase I Study to Determine Safety of Experimental Antibody | May 22, 2013 |
| UPDATED: Clinical Trial Results Announced in Study of Peginterferon Beta-1a - Company Submits Application to FDA | May 21, 2013 |
| Studies Report Progress Understanding What Drives Repair of the Brain’s Insulating Myelin, Which is Damaged by MS | May 08, 2013 |
| Study Finds that the Incidence of MS Appears to be Higher in African American Women Than in Caucasians, Contradicting Previous Findings | May 06, 2013 |
| Bimbo Bakeries USA and Flowers Foods “Summer Bun” Program Benefits National MS Society | May 04, 2013 |
| Positive Results Announced for Aubagio in Phase III Study of People at High Risk for MS | Apr 26, 2013 |
| Results Published from Phase II Trial of Daclizumab in Relapsing MS | Apr 25, 2013 |
| Cases of PML Reported in People Taking Fumarate-based Treatments for Psoriasis - No cases reported in People with MS Taking Related Product, Tecfidera | Apr 24, 2013 |
| MS Trial Alert: Drug Study at NIH Recruiting People with Primary-Progressive MS | Apr 22, 2013 |
| Meeting of MS Outcome Assessments Consortium and FDA Clears Pathway for New Tool for Clinical Trials in MS, Particularly Progressive Forms | Apr 18, 2013 |
| $18 Million in New Research Projects Launched To Stop MS, Restore Function and End It Forever - Part of 2013 investment of over $47 million in cutting-edge research projects | Apr 18, 2013 |
| National MS Society statement concerning the Boston Marathon | Apr 16, 2013 |
| MS Trial Alert: Drug Study at NIH Recruiting People with Secondary-Progressive MS | Apr 15, 2013 |
| Month of Birth May Influence Risk of MS by Promoting Changes in Immune System Development | Apr 15, 2013 |
| National MS Society Partners with the University of Miami and Accera, Inc. to Test Novel “Medical Food” for MS Cognitive Impairment | Apr 11, 2013 |
| New Study Reports That an Online Community of People with MS May Be Used to Study the Disease | Apr 11, 2013 |
| Emerging Therapies, Risk Factors and Other MS Research News from American Academy of Neurology Meeting | Apr 10, 2013 |
| Canbex Therapeutics Raises $ 3.2 million to Develop Treatment for Debilitating Muscle Spasms Associated with MS | Apr 09, 2013 |
| Annette Funicello, beloved 1950s Disney “Mouseketeer” and 1960s movie star, died April 8th at the age of 70 from complications of multiple sclerosis | Apr 08, 2013 |
| SOCIETY CO-SPONSORS RALLY FOR MEDICAL RESEARCH | Apr 05, 2013 |
| Sam’s Club: Maximizing a local relationship and making a nationwide difference | Apr 05, 2013 |
| The National MS Society Commends and Supports President Obama’s Announced Brain Research Initiative | Apr 02, 2013 |
| FDA Approves Twice a Day Capsules Called Tecfidera™ (formerly called BG-12) for Relapsing MS | Mar 27, 2013 |
| Oxford’s Professor George Ebers Wins 2013 John Dystel Prize for MS Research: Revolutionized our understanding of MS | Mar 21, 2013 |
| Dr. Stephen Hauser, National MS Society Leadership Volunteer, Wins Charcot Award | Mar 15, 2013 |
| Every Connection Counts during MS Awareness Week, March 11-17 | Mar 11, 2013 |
| National MS Society-Supported Studies Point to Possibility That Dietary Salt May Stimulate Activity of Key Immune Cells Involved in MS Attacks | Mar 06, 2013 |
| Researchers report on brain imaging to detect tissue damage associated with cognitive impairment in MS – may help determine benefits of treatments | Mar 06, 2013 |
| First Published Results from National MS Society-Funded CCSVI Study | Mar 05, 2013 |
| National MS Society Joins Collaborative Effort to Identify and Speed Development of Nerve-Protecting Drugs | Feb 28, 2013 |
| Researchers Gather for First Scientific Meeting of the International Progressive MS Collaborative – challenges and opportunities identified | Feb 27, 2013 |
| National MS Society Mourns Passing of Staff Member Dr. Patricia O’Looney, Vice President of Biomedical Research | Feb 19, 2013 |
| National MS Society-Supported Researchers Report that Skin-derived Stem Cells from People Generate New Nerve-Insulating Myelin in Mice | Feb 13, 2013 |
| Study: Obesity is Associated with Increased Risk of MS in Girls | Jan 30, 2013 |
| Sam’s Club fundraiser to benefit the Society | Jan 17, 2013 |
| Researchers Recruiting 5,000 First-Degree Relatives of People with MS for Genetic/Environmental Research Study | Jan 14, 2013 |
| UCSF DNA Bank Seeks Participants to Help End MS | Jan 14, 2013 |
| Study Suggests Eyes Offer Unique Window to MS Damage and Repair -- - May represent new way to track benefits of therapy during clinical trials in progressive MS | Jan 09, 2013 |
| Fast Forward, LLC and EMD Serono, Inc. Announce Recipients of Funding for Multiple Sclerosis Research -- up to $1.4 million in 2012 to accelerate early-stage research in MS | Dec 20, 2012 |
| MS Trial Alert: Investigators Recruiting People with MS for Study of New Investigational Dosage of Approved Medication for Urinary Incontinence | Dec 17, 2012 |
| Fast Forward Partner Apitope International N.V. Reaches Key Milestone in Phase I Peptide Therapy Study | Dec 14, 2012 |
| 2012: Sweeping Advances Made in MS Research | Dec 11, 2012 |
| $25 Million in New Research Projects Launched to Stop MS, Restore Function, and End It Forever | Dec 11, 2012 |
| National Multiple Sclerosis Society and Critical Path Institute Create the Multiple Sclerosis Outcome Assessments Consortium | Dec 06, 2012 |
| Researchers co-funded by the National MS Society discover possible mechanism for MS damage to nerve tissue in mice | Dec 02, 2012 |
| High levels of vitamin D among pregnant women are associated with reduced risk of developing MS later | Nov 20, 2012 |
| New Experimental Strategy to Turn Off Immune Attacks in MS Uses “Nanoparticles” | Nov 19, 2012 |
| Fast Forward Collaborations Aim to Speed MS Diagnosis and Monitoring | Nov 15, 2012 |
| New Prize Launched To Recognize Innovative Research in MS -- Barancik Prize largest ever cash prize to spur progress toward a cure | Nov 12, 2012 |
| Male sex hormone testosterone shows nerve-protecting capabilities in mice with MS-like disease | Nov 06, 2012 |
| Results published of successful phase III trials of intravenous alemtuzumab for relapsing MS | Nov 05, 2012 |
| Results of More Than 1250 Studies Shared at Global MS Research Meeting | Oct 29, 2012 |
| MS Trial Alert: Investigators Recruiting for Personalized T Cell Immunotherapy Study in Secondary-Progressive MS | Oct 22, 2012 |
| Weight Training Improves Walking and Quality of Life in a Small Study of Women with MS: Unique Society-supported study design features in-depth interviews with participants | Oct 22, 2012 |
| Study Takes Step Towards Personalized Medicine for Prognosis and Treatment in MS | Sep 28, 2012 |
| Update: Canadian Government Announces Research Team Launching Clinical Trial to Treat CCSVI | Sep 28, 2012 |
| Ginkgo Fails to Improve Cognitive Function in People with MS | Sep 24, 2012 |
| Results published of successful phase III trials of oral BG-12 for relapsing MS | Sep 19, 2012 |
| FDA Approves Oral Teriflunomide – Brand Name Aubagio® – as Disease-Modifying Therapy for Relapsing MS | Sep 12, 2012 |
| MS Societies Worldwide Collaborate to Stop MS Progression – “The time is right for concerted action” | Sep 10, 2012 |
| Bimbo Bakeries USA Back to School Promotion to Benefit Society’s Scholarship Fund | Sep 07, 2012 |
| Researchers Continue With Their Progress in the Seven Society-Funded CCSVI Studies in MS | Sep 04, 2012 |
| UPDATED: Genzyme Applies to FDA for Approval of Alemtuzumab to Treat Relapsing MS | Aug 27, 2012 |
| MS Trial Alert: Investigators Recruiting for Study of Tysabri in Early Relapsing-Remitting MS | Aug 24, 2012 |
| National MS Society Task Force Launches Ambitious Project to Change How MS Disability and Progression is Measured | Aug 22, 2012 |
| Fast Forward and the University of Cambridge collaborate to find new drugs that will repair the nervous system in people with MS | Aug 20, 2012 |
| Ampyra Post-Marketing Study Results Announced - Low dose does not improve walking: Approved dose misses primary endpoint but shows benefit in several secondary endpoints | Aug 14, 2012 |
| New Information Posted on Clinical Trials in MS | Jul 31, 2012 |
| New Studies Focus on Vitamin D and MS | Jul 31, 2012 |
| FDA Updates Prescribing Info for Ampyra to Address Risk of Seizure in Those with Reduced Kidney Function | Jul 23, 2012 |
| Researchers Suggest Immune B Cells from People with MS May Produce Substances That Are Toxic to Brain Cells | Jul 17, 2012 |
| Study Suggests That Interferons Did Not Reduce MS Progression | Jul 17, 2012 |
| Stress Management Reduces MRI-Detected Disease Activity in New Study of People with MS | Jul 13, 2012 |
| Study Identifies Possible Target of Immune Attacks in Some People with MS | Jul 11, 2012 |
| $18.4 Million in New Research and Training Projects Launched to Stop Multiple Sclerosis, Restore Function and End it Forever -- 52 new grants and fellowships part of over $43 million 2012 investment in cutting-edge research projects moving us closer to a world free of MS | Jul 09, 2012 |
| Italian Researchers Find that MS Disease-Modifying Therapies Reduce the Risk of Future MS Progression | Jul 03, 2012 |
| Small Study Suggests Botox Injections Improve Arm Tremor in People with MS – Larger trial needed to confirm and expand findings | Jul 03, 2012 |
| U.S. Supreme Court rules on the Patient Protection & Affordable Care Act | Jun 28, 2012 |
| Clinical Trial Shows Teriflunomide Pill Reduces Relapses in Relapsing-Remitting MS | Jun 04, 2012 |
| Survey of MS Specialists Suggests People Are Commonly Misdiagnosed as Having Multiple Sclerosis | May 30, 2012 |
| Making Connections Around The Globe to End MS | May 30, 2012 |
| Fast Forward, LLC funds Axxam SpA for the development of compounds to help prevent disability in Multiple Sclerosis | May 30, 2012 |